Reports on growing opposition to a proposal by Harold Varmus, director of the US National Institutes of Health (NIH), to disband the agency's Recombinant DNA Advisory Committee (RAC). The committee's responsibility for reviewing and approving novel gene-therapy protocols; Varmus' wish to hand over this function to the US Food and Drug Administration (FDA).